
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PELP1 CRISPR/Cas9 KO Plasmid (m) | sc-429042 | 20 µg | $397.00 |
PELP1 (proline-, glutamic acid-, and leucine-rich protein 1), encoded by the mouse Pelp1 gene, is a multifunctional nuclear receptor coregulator and chromatin-associated scaffold that integrates steroid hormone signaling with transcriptional and epigenetic control. It coordinates interactions between estrogen receptor signaling and chromatin remodeling complexes, influencing RNA polymerase II–dependent transcription, histone modifications, and cell-cycle progression. PELP1 also interfaces with kinase pathways and DNA damage responses, linking growth factor cues to gene expression programs and genome maintenance. Dysregulated PELP1 activity and localization have been associated with aberrant proliferation, altered endocrine signaling, and oncogenic transcriptional networks, making it relevant for mechanistic studies of hormone-responsive biology and tumor-associated pathways.
PELP1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Pelp1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Pelp1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Pelp1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish PELP1 protein expression.
This CRISPR knockout system enables efficient generation of Pelp1-deficient cell models for investigation of PELP1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.